Home LiteratureArticle Details
PMID: 2153711 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene.

The Journal of clinical investigation ·Vol. 85 ·No. 2 ·1990-02-00 ·Pages 563-9

Goldberg M, Belkowski LS, Bloom BR

Abstract

The importance of oxidative cytocidal mechanisms of phagocytic cells in immune protection against microbial pathogens is uniquely revealed by chronic granulomatous disease (CGD), a genetic deficiency disease of man. This cytocidal response in mononuclear phagocytes is principally regulated by IFN-gamma. A somatic cell genetic approach was taken to select oxidative variants from a cloned murine macrophage cell line, J774.16, which formally permitted us to dissociate three regulatory effects of IFN-gamma on these cells: the antiproliferative effect, the antiviral effect, and production of superoxide anion. Half of the variants defective in O-2 production after phorbol myristate acetate stimulation were also resistant to the antiproliferative effects of IFN-gamma. This result suggests that IFN-gamma-induced growth inhibition and production of cytocidal oxygen intermediates are mediated via a common pathway. The somatic cell genetic approach has allowed us to develop in vitro macrophage models for several forms of CGD. One variant characterized in detail, D9, was unable to produce superoxide after stimulation by phorbol esters. At the molecular level, Northern blot analysis revealed that the mRNA encoding the large subunit of the putative CGD gene product, cytochrome b558, was absent in this variant. Another class of variants constitutively unable to produce O-2 or the cytochrome b558 mRNA could be induced to do so by IFN-gamma. These somatic mutants may be useful models in clarifying the role of the CGD gene product and its regulation in the production of cytocidal oxygen intermediates.

MeSH Terms
Animals Cell Line Gene Expression Granulomatous Disease, Chronic/genetics Interferon-gamma/pharmacology Macrophages/drug effects,physiology Mice Mutation Oxidation-Reduction Superoxides/metabolism Tetradecanoylphorbol Acetate/pharmacology X Chromosome
Chemicals
Superoxides Interferon-gamma Tetradecanoylphorbol Acetate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Goldberg M
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.
Belkowski L S
Bloom B R
References (30)
30 references, click to expand
  1. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.
    J Clin Invest. 1967 Sep;46(9):1422-32 PMID: 6036538
  2. B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome.
    J Immunol. 1984 Dec;133(6):3006-9 PMID: 6092465
  3. Macrophage variants in oxygen metabolism.
    J Exp Med. 1980 Oct 1;152(4):808-22 PMID: 6252274
  4. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.
    J Exp Med. 1982 Dec 1;156(6):1780-93 PMID: 6816896
  5. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance.
    N Engl J Med. 1983 Feb 3;308(5):245-51 PMID: 6848934
  6. Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon.
    J Immunol. 1983 Jul;131(1):315-8 PMID: 6408177
  7. Lymphokine enhances oxygen-independent activity against intracellular pathogens.
    J Exp Med. 1983 Jul 1;158(1):234-9 PMID: 6864162
  8. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.
    J Clin Invest. 1983 Jul;72(1):393-7 PMID: 6192145
  9. Growth of Trypanosoma cruzi in a cloned macrophage cell line and in a variant defective in oxygen metabolism.
    Infect Immun. 1983 Sep;41(3):1322-31 PMID: 6350185
  10. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    J Exp Med. 1983 Sep 1;158(3):670-89 PMID: 6411853
  11. Oxygen metabolism in cloned macrophage cell lines: glucose dependence of superoxide production, metabolic and spectral analysis.
    J Immunol. 1984 Feb;132(2):857-66 PMID: 6317750
  12. Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease.
    Nature. 1984 Feb 9-15;307(5951):553-5 PMID: 6320013
  13. Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon.
    J Cell Biol. 1984 Apr;98(4):1342-7 PMID: 6325469
  14. Activation of murine macrophage cell lines. Possible involvement of protein kinases in stimulation of superoxide production.
    J Immunol. 1984 Aug;133(2):923-31 PMID: 6330204
  15. Activation of human macrophages. Comparison of other cytokines with interferon-gamma.
    J Exp Med. 1984 Aug 1;160(2):600-5 PMID: 6206183
  16. Chronic granulomatous disease: correlation between pathogenesis and clinical findings.
    Pediatrics. 1971 Nov;48(5):730-9 PMID: 5121235
  17. Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.
    J Biol Chem. 1985 Feb 10;260(3):1378-81 PMID: 3155735
  18. Monoclonal antibody-mediated inhibition of interferon-gamma-induced macrophage antiviral resistance and surface antigen expression.
    J Immunol. 1986 Apr 15;136(8):2917-23 PMID: 3007607
  19. A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein.
    J Clin Immunol. 1986 Mar;6(2):136-45 PMID: 3011845
  20. A T cell-independent mechanism of macrophage activation by interferon-gamma.
    J Immunol. 1987 Aug 15;139(4):1104-7 PMID: 3112223
  21. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    J Clin Invest. 1988 Feb;81(2):606-10 PMID: 3339133
  22. Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils. Defects in the phosphorylation of a group of closely related 48-kDa proteins in two forms of chronic granulomatous disease.
    J Biol Chem. 1988 May 15;263(14):6777-82 PMID: 3360806
  23. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.
    Proc Natl Acad Sci U S A. 1988 May;85(10):3319-23 PMID: 3368442
  24. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
    N Engl J Med. 1988 Jul 21;319(3):146-51 PMID: 2838754
  25. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4874-8 PMID: 2838849
  26. Classification of chronic granulomatous disease.
    Hematol Oncol Clin North Am. 1988 Jun;2(2):241-52 PMID: 2839457
  27. Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5122-5 PMID: 3134657
  28. Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5215-9 PMID: 2839835
  29. Molecular genetics of chronic granulomatous disease.
    Annu Rev Immunol. 1989;7:277-307 PMID: 2523713
  30. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    J Cell Biol. 1989 Sep;109(3):1331-40 PMID: 2549078
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1990-02-00
Pages
563-9
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC296459
Subset
IM
Grants
NIAID NIH HHS · AI-02111 · United States
NIAID NIH HHS · AI-07118 · United States
NIAID NIH HHS · AI-09807 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com